Paul A. Wagner
2021 - Forte Biosciences
In 2021, Paul A. Wagner earned a total compensation of $5.4M as Chairman and Chief Executive Officer at Forte Biosciences, a 597% increase compared to previous year.
Compensation breakdown
| Bonus | $162,500 |
|---|---|
| Option Awards | $4,367,948 |
| Salary | $590,000 |
| Stock Awards | $294,998 |
| Total | $5,415,196 |
Wagner received $4.4M in option awards, accounting for 81% of the total pay in 2021.
Wagner also received $162.5K in bonus, $590K in salary and $295K in stock awards.
Rankings
In 2021, Paul A. Wagner's compensation ranked 2,370th out of 12,415 executives tracked by ExecPay. In other words, Wagner earned more than 80.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,370 out of 12,415 | 81st |
Division Manufacturing | 934 out of 5,508 | 83rd |
Major group Chemicals And Allied Products | 356 out of 2,378 | 85th |
Industry group Drugs | 309 out of 2,099 | 85th |
Industry Pharmaceutical Preparations | 201 out of 1,549 | 87th |
Source: SEC filing on April 29, 2022.
Wagner's colleagues
We found one more compensation record of an executive who worked with Paul A. Wagner at Forte Biosciences in 2021.
2021
Antony Riley
Forte Biosciences